Back

Free triiodothyronine/free thyroxine ratio as a predictor of mortality in LVAD recipients during 12 months of observations

13 May 2024 (14:00 - 15:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - treatment 6 Ventricular Assist Devices HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Sylwia Wisniowska-Smialek

Jagiellonian University Medical College, John Paul II Hospital, Krakow (Poland)

7 More presentations in this session

Presentation thumbnail
Identifying predictors of non-response to cardiac resynchronization therapy in heart failure patients
Doctor L. Pinheiro (Guimaraes, PT)
Abstract Slides Video
Presentation thumbnail
Predictors of cardiac resynchronized therapy response and maximum allowable medical treatment period in dilated cardiomyopathy with left bundle branch block
Doctor M. Bak (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Cardiac resynchronisation therapy's response in patients with atrial fibrillation
Doctor A. Ferreira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Longitudinal assessment of ventricular arrhythmia burden before and after left ventricular assist device implantation: implications for risk stratification and postoperative management
Professor M. Kim (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Incidence and predictors of heart failure hospitalization after left ventricular assist device insertion
Doctor M. Bak (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - treatment 6

The Event

Event poster

Heart Failure 2024

13 May 2024 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic impact of thyroid dysfunction in patients with incident heart failure: a nationwide study
thumbnail
Congress Presentation
Frailty, inflammation, prognosis and thyroid hormones in heart failure: the clinical relevance of the FT3/FT4 ratio
thumbnail
Congress Presentation
Predictors of one-year outcome in heart failure with preserved and mildly-reduced ejection fraction - results from the national multicentre HF-POL registry

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources